Cardio Diagnostics HoldingsCDIO

13F holders, Q2 2025 (June 30)
16holders
$3.60avg. 13F price*

At the end of Q2 2025, 16 institutions reported holding Cardio Diagnostics Holdings (CDIO) in their 13F filings. The largest holders were BlackRock, Inc. ($128K), Geode Capital Management, LLC ($48K) and Susquehanna International Group, LLP ($47K).

Company
Cardio Diagnostics Holdings
CUSIP
14159C202
Latest filing quarter
Q2 2026

History

Number of 13F holders

05101520 Q2 2025: 16Q2 2025Q3 2025: 14Q3 2025Q4 2025: 16Q4 2025Q1 2026: 16Q1 2026Q2 2026: 17Q2 2026

Total Exit/New Position Q2 2025

InstitutionsTotal Value
New Positions4$74K
Exits0$0

Ownership 16 holders

BlackRock, Inc. 0.00% No change 35,567 $128K
Geode Capital Management, LLC 0.00% Add +1.5% 13,365 $48K
Susquehanna International Group, LLP 0.00% New 13,060 $47K
Vanguard Group Inc. 0.00% Add +2.1% 12,682 $46K
Royal Bank of Canada 0.00% New 7,500 $27K
PNC Financial Services Group, Inc. 0.00% No change 1,350 $5K
UBS Group AG 0.00% Reduce -87.5% 697 $3K
Osaic Holdings, Inc. 0.00% Reduce -47.4% 107 $383
Wolverine Asset Management LLC 0.00% Reduce -1.0% 104 $374
Morgan Stanley 0.00% Reduce -33.3% 100 $360
Tower Research Capital LLC (TRC) 0.00% Reduce -83.5% 100 $360
SBI Securities Co., Ltd. 0.00% Add +15.3% 70 $252
Bank of America Corp. 0.00% Add +44.2% 15 $54
Arax Advisory Partners 0.00% New 6 $22
FMR LLC 0.00% New 3 $11
Cwm, LLC 0.00% No change 116 $0

"% of holder's portfolio" is CDIO's weight in each manager's 13F, not the share of Cardio Diagnostics Holdings the manager owns.